CA19-9

Open Access
Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
YUTARO KUBOTA, QINGHONG HAN, CHIHIRO HOZUMI, NORIYUKI MASAKI, JUN YAMAMOTO, YUSUKE AOKI, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research May 2022, 42 (5) 2567-2572; DOI: https://doi.org/10.21873/anticanres.15734
You have access
The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer
KEISHI OKUBO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, YOSHIKAZU UENOSONO, SHIGEHIRO YANAGITA, TAKASHI KIJIMA, YUSUKE TSURUDA, MASAHIRO NODA, KEN SASAKI, SHINICHIRO MORI, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research November 2021, 41 (11) 5643-5649; DOI: https://doi.org/10.21873/anticanres.15380
You have access
Clinical Predictors of Unresectable Disease at Laparotomy in Patients With Pancreatic Ductal Adenocarcinoma Planning to Undergo Surgical Resection
TAKAYUKI SHIMIZU, TAKU AOKI, SHUN SATO, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUHKI SAKURAOKA, SHOZO MORI, YUKIHIRO ISO, MITSURU ISHIZUKA and KEIICHI KUBOTA

Anticancer Research October 2021, 41 (10) 5171-5177; DOI: https://doi.org/10.21873/anticanres.15335
You have access
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU

Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
You have access
Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma
SHOGO OHTA, YUJI MORINE, SATORU IMURA, TETSUYA IKEMOTO, YUSUKE ARAKAWA, SHUICHI IWAHASHI, YU SAITO, SHINICHIRO YAMADA, YUMA WADA, SHOKO YAMASHITA, YOSHIMI BANDO and MITSUO SHIMADA

Anticancer Research November 2019, 39 (11) 6025-6033; DOI: https://doi.org/10.21873/anticanres.13808
You have access
The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer
CHRISTOPHER MÅNSSON, ANDERS NILSSON, JOZEF URDZIK and BRITT-MARIE KARLSON

Anticancer Research November 2019, 39 (11) 6193-6196; DOI: https://doi.org/10.21873/anticanres.13827
You have access
High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma
HIROSHI YAEGASHI, KOUJI IZUMI, SUGURU KADOMOTO, RENATO NAITO, TOMOYUKI MAKINO, HIROAKI IWAMOTO, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research January 2019, 39 (1) 375-380; DOI: https://doi.org/10.21873/anticanres.13122
You have access
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS

Anticancer Research May 2017, 37 (5) 2185-2194;
You have access
Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays
RAMONA C. DOLSCHEID-POMMERICH, STEFFEN MANEKELLER, GISELA WALGENBACH-BRÜNAGEL, JÖRG C. KALFF, GUNTHER HARTMANN, BIRGIT STOFFEL WAGNER and STEFAN HOLDENRIEDER

Anticancer Research January 2017, 37 (1) 353-359;
You have access
Better Outcomes by Monitoring Tumour Dynamics Using Sensitive Tumour Markers in Patients with Recurrent Gastric Cancer
SHUHEI KOMATSU, DAISUKE ICHIKAWA, YUKIHISA NISHIMURA, TAKESHI KUBOTA, KAZUMA OKAMOTO, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, HIROTAKA KONISHI, YASUTOSHI MURAYAMA, YOSHIAKI KURIU, HISASHI IKOMA, MASAYOSHI NAKANISHI and EIGO OTSUJI

Anticancer Research April 2013, 33 (4) 1621-1627;

Main menu

User menu

Search

CA19-9

Pages